GB0018686D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB0018686D0
GB0018686D0 GB0018686A GB0018686A GB0018686D0 GB 0018686 D0 GB0018686 D0 GB 0018686D0 GB 0018686 A GB0018686 A GB 0018686A GB 0018686 A GB0018686 A GB 0018686A GB 0018686 D0 GB0018686 D0 GB 0018686D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0018686A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0018686A priority Critical patent/GB0018686D0/en
Publication of GB0018686D0 publication Critical patent/GB0018686D0/en
Priority to AU22068/01A priority patent/AU2206801A/en
Priority to AT00985666T priority patent/ATE291898T1/en
Priority to ES00985666T priority patent/ES2238334T3/en
Priority to DE60019167T priority patent/DE60019167T2/en
Priority to JP2001548088A priority patent/JP2003518484A/en
Priority to EP00985666A priority patent/EP1248597B1/en
Priority to PCT/GB2000/004939 priority patent/WO2001047493A1/en
Priority to US10/168,672 priority patent/US20030032632A1/en
Ceased legal-status Critical Current

Links

GB0018686A 1999-12-24 2000-07-28 Pharmaceutical formulation Ceased GB0018686D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0018686A GB0018686D0 (en) 2000-07-28 2000-07-28 Pharmaceutical formulation
AU22068/01A AU2206801A (en) 1999-12-24 2000-12-21 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
AT00985666T ATE291898T1 (en) 1999-12-24 2000-12-21 PHARMACEUTICAL AEROSOL FORMULATION CONTAINING SALMETEROL AND FLUTICASONE
ES00985666T ES2238334T3 (en) 1999-12-24 2000-12-21 PHARMACEUTICAL FORMULATION IN SALMETEROL AEROSOL AND FLUTICASONA PROPIONATE.
DE60019167T DE60019167T2 (en) 1999-12-24 2000-12-21 PHARMACEUTICAL AEROSOL FORMULATION CONTAINING SALMETEROL AND FLUTICASONE
JP2001548088A JP2003518484A (en) 1999-12-24 2000-12-21 Pharmaceutical aerosol formulations of salmeterol and fluticasone propionate
EP00985666A EP1248597B1 (en) 1999-12-24 2000-12-21 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
PCT/GB2000/004939 WO2001047493A1 (en) 1999-12-24 2000-12-21 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
US10/168,672 US20030032632A1 (en) 1999-12-24 2000-12-21 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0018686A GB0018686D0 (en) 2000-07-28 2000-07-28 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB0018686D0 true GB0018686D0 (en) 2000-09-20

Family

ID=9896635

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0018686A Ceased GB0018686D0 (en) 1999-12-24 2000-07-28 Pharmaceutical formulation

Country Status (1)

Country Link
GB (1) GB0018686D0 (en)

Similar Documents

Publication Publication Date Title
IL156716A0 (en) Pharmaceutical formulation
GB0118689D0 (en) Pharmaceutical formulation
PL366432A1 (en) Pharmaceutical formulation
PL366067A1 (en) Oxayolidinone tablet formulation
GB9909154D0 (en) Pharmaceutical formulation
GB0014851D0 (en) Novel pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
GB0014947D0 (en) Novel pharmaceutical formulation
GB0014892D0 (en) Novel pharmaceutical formulation
GB0014883D0 (en) Novel pharmaceutical formulation
GB0021487D0 (en) Pharmaceutical
EP1414417A4 (en) Pharmaceutical formulation
GB0104749D0 (en) Pharmaceutical formulation
GB0014869D0 (en) Novel pharmaceutical formulation
GB0014849D0 (en) Pharmaceutical aerosol formulation
GB0019084D0 (en) Pharmaceutical formulation
GB0018686D0 (en) Pharmaceutical formulation
GB0018654D0 (en) Pharmaceutical formulation
GB0014451D0 (en) Pharmaceutical formulation
GB0014424D0 (en) Pharmaceutical formulation
GB0019840D0 (en) Novel pharmaceutical formulation
GB0002691D0 (en) Pharmaceutical composition
GB0124712D0 (en) Pharmaceutical formulation
GB9910636D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)